BlackRock Japan’s NanoViricides NNVC Stock Holding History

BlackRock Japan’s Portfolio NNVC Stock Details NNVC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-91	Closed	-$3K	–	1330
2015 Q2	$3K	Buy	+91	New	+$3.47K	﹤0.01%	1323

Other funds holding NNVC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

SIP

Stoneridge Investment Partners Radnor, Pennsylvania $152M AUM 20.58% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

BlackRock Japan's NNVC Position: Q3 2015 in Review

BlackRock Japan sold out of NanoViricides (NNVC) in Q3 2015, closing a stake of 91 shares — an estimated $3K sold.

BlackRock Japan first reported a position in NNVC in Q2 2015 and held it in 1 quarter. The position peaked at $3K in Q2 2015. 45 funds tracked by Wall St. Rank hold NNVC as of Q3 2015.

BlackRock Japan reported no remaining NanoViricides position as of Q3 2015 after selling out during the quarter.
BlackRock Japan sold 91 NanoViricides shares in Q3 2015, an estimated $3K.
BlackRock Japan first reported a position in NanoViricides in Q2 2015 and held it in 1 quarter.
BlackRock Japan's NanoViricides position peaked at $3K in Q2 2015.
45 funds tracked by Wall St. Rank held NanoViricides as of Q3 2015.

Based on BlackRock Japan's 13F filing for Q3 2015, filed 13 Nov 2015.